Monopar Therapeutics (MNPR) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Monopar Therapeutics?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Monopar Therapeutics's filing signal
continuing positive.
earningsVibe SuperAnalyst™ Verdict:
CONTINUING POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Continuing Negative
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Monopar Therapeutics actually do?
Answer:
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. Its lead Wilson disease candidate, ALXN1840, is an orally administered medicine that targets copper removal, having received Orphan Drug and Fast Track designations. The company's oncology pipeline includes MNPR-101-Zr for imaging advanced cancers and MNPR-101-Lu and MNPR-101-Ac for treating uPAR-expressing cancers. Monopar builds its pipeline through in-house efforts and licensing, aiming to leverage scientific and clinical expertise to accelerate development.
Question:
What are Monopar Therapeutics's revenue drivers?
Answer:
Monopar Therapeutics is a clinical-stage company and has not generated any revenue from product sales. It anticipates revenue generation only after completing development, obtaining marketing approval for its product candidates, or through out-licensing or collaboration agreements.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required